Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney
Yan Yuan, Mengyao Sun, Zijie Jin, Zheng Chen, Huijing Ye, Hongbo Weng
Topics & Concepts
DapagliflozinHMGB1InflammationKidneyEndocrinologyInternal medicineTumor necrosis factor alphaDiabetes mellitusDiabetic nephropathyMedicineType 2 diabetesAdvanced Glycation End Products researchDiabetes Treatment and ManagementChronic Kidney Disease and Diabetes